{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T13:16:20Z","timestamp":1769951780635,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier","isbn-type":[{"value":"9780443338410","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/b978-0-443-33841-0.00030-0","type":"book-chapter","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:50:41Z","timestamp":1769907041000},"page":"375-382","source":"Crossref","is-referenced-by-count":0,"title":["Alzheimer\u2019s disease: diabetes of the brain"],"prefix":"10.1016","author":[{"given":"Paula I.","family":"Moreira","sequence":"first","affiliation":[]},{"given":"Susana","family":"Cardoso","sequence":"additional","affiliation":[]},{"given":"George","family":"Perry","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/B978-0-443-33841-0.00030-0_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: Concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nature Reviews Neurology"},{"issue":"3","key":"10.1016\/B978-0-443-33841-0.00030-0_bib2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3233\/JAD-2009-1155","article-title":"Insulin is a two-edged knife on the brain","volume":"18","author":"Cardoso","year":"2009","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/B978-0-443-33841-0.00030-0_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2023.102694","article-title":"Metabolic defects shared by Alzheimer\u2019s disease and diabetes: A focus on mitochondria","volume":"79","author":"Carvalho","year":"2023","journal-title":"Current Opinion in Neurobiology"},{"issue":"10","key":"10.1016\/B978-0-443-33841-0.00030-0_bib4","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/gerona\/glu073","article-title":"Type 2 diabetes and antidiabetic medications in relation to dementia diagnosis","volume":"69","author":"Cheng","year":"2014","journal-title":"Journals of Gerontology - Series A Biological Sciences and Medical Sciences"},{"issue":"2","key":"10.1016\/B978-0-443-33841-0.00030-0_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.15252\/emmm.201404183","article-title":"Alzheimer-associated A\u03b2 oligomers impact the central nervous system to induce peripheral metabolic deregulation","volume":"7","author":"Clarke","year":"2015","journal-title":"EMBO Molecular Medicine"},{"issue":"3","key":"10.1016\/B978-0-443-33841-0.00030-0_bib6","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3233\/JAD-141791","article-title":"Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer\u2019s Disease dementia","volume":"44","author":"Claxton","year":"2015","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"1","key":"10.1016\/B978-0-443-33841-0.00030-0_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: A pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Archives of Neurology"},{"issue":"4","key":"10.1016\/B978-0-443-33841-0.00030-0_bib8","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3233\/JAD-161256","article-title":"Effects of regular and long-acting insulin on cognition and Alzheimer\u2019s disease biomarkers: A pilot clinical trial","volume":"57","author":"Craft","year":"2017","journal-title":"Journal of Alzheimer\u2019s Disease."},{"issue":"9","key":"10.1016\/B978-0-443-33841-0.00030-0_bib9","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","article-title":"Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: A randomized clinical trial","volume":"77","author":"Craft","year":"2020","journal-title":"JAMA Neurology"},{"key":"10.1016\/B978-0-443-33841-0.00030-0_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.exger.2017.07.004","article-title":"A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer\u2019s disease","volume":"107","author":"Croteau","year":"2018","journal-title":"Experimental Gerontology"},{"issue":"9","key":"10.1016\/B978-0-443-33841-0.00030-0_bib11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","article-title":"Brain energy rescue: An emerging therapeutic concept for neurodegenerative disorders of ageing","volume":"19","author":"Cunnane","year":"2020","journal-title":"Nature Reviews Drug Discovery"},{"issue":"11","key":"10.1016\/B978-0-443-33841-0.00030-0_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079977","article-title":"Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer\u2019s mouse brain: Implication for bioenergetic intervention","volume":"8","author":"Ding","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/B978-0-443-33841-0.00030-0_bib13","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/alz.12482","article-title":"The impact of diabetes on cognitive impairment and its progression to dementia","volume":"17","author":"Dove","year":"2021","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/B978-0-443-33841-0.00030-0_bib14","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2147\/DDDT.S409373","article-title":"Metformin: A review of potential mechanism and therapeutic utility beyond diabetes","volume":"17","author":"Dutta","year":"2023","journal-title":"Drug Design, Development and Therapy"},{"issue":"7","key":"10.1016\/B978-0-443-33841-0.00030-0_bib15","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid \u03b2-protein, and the \u03b2-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1016\/B978-0-443-33841-0.00030-0_bib16","article-title":"A comprehensive review of intranasal insulin and its effect on the cognitive function of diabetics","volume":"13","author":"Gaddam","year":"2021","journal-title":"Cureus"},{"issue":"MAY","key":"10.1016\/B978-0-443-33841-0.00030-0_bib17","article-title":"In Alzheimer\u2019s disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: Randomized, placebo-controlled, double-blind clinical trial","volume":"8","author":"Gejl","year":"2016","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"2","key":"10.1016\/B978-0-443-33841-0.00030-0_bib18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3233\/JAD-180297","article-title":"Metabolic syndrome and amyloid accumulation in the aging brain","volume":"65","author":"Gomez","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease."},{"issue":"2","key":"10.1016\/B978-0-443-33841-0.00030-0_bib19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1042\/bst0280170","article-title":"Mitochondria and cell death","volume":"28","author":"Halestrap","year":"2000","journal-title":"Biochemical Society Transactions"},{"issue":"1","key":"10.1016\/B978-0-443-33841-0.00030-0_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00005072-199501000-00005","article-title":"Functional alterations in Alzheimers disease decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone","volume":"54","author":"Harr","year":"1995","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"5","key":"10.1016\/B978-0-443-33841-0.00030-0_bib21","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2174\/156720511796391935","article-title":"Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimers disease: Two phase 3 studies","volume":"8","author":"Harrington","year":"2011","journal-title":"Current Alzheimer Research"},{"issue":"2","key":"10.1016\/B978-0-443-33841-0.00030-0_bib22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ana.24439","article-title":"Effect of pioglitazone medication on the incidence of dementia","volume":"78","author":"Heneka","year":"2015","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1016\/B978-0-443-33841-0.00030-0_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0167-4943(82)90021-8","article-title":"The abnormally aged brain. Its blood flow and oxidative metabolism. A review \u2014 Part II","volume":"1","author":"Hoyer","year":"1982","journal-title":"Archives of Gerontology and Geriatrics"},{"issue":"3","key":"10.1016\/B978-0-443-33841-0.00030-0_bib24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3233\/JAD-2011-101524","article-title":"Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin","volume":"24","author":"Hsu","year":"2011","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"2","key":"10.1016\/B978-0-443-33841-0.00030-0_bib25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","article-title":"Increased risk of type 2 diabetes in Alzheimer disease","volume":"53","author":"Janson","year":"2004","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/B978-0-443-33841-0.00030-0_bib26","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1471-4159.1989.tb07399.x","article-title":"Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease","volume":"53","author":"Kalaria","year":"1989","journal-title":"Journal of Neurochemistry"},{"issue":"11","key":"10.1016\/B978-0-443-33841-0.00030-0_bib27","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jamaneurol.2019.2462","article-title":"Association of extracellular vesicle biomarkers with Alzheimer disease in the baltimore longitudinal study of aging","volume":"76","author":"Kapogiannis","year":"2019","journal-title":"JAMA Neurology"},{"key":"10.1016\/B978-0-443-33841-0.00030-0_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pnpbp.2017.06.002","article-title":"Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus","volume":"79","author":"Kuan","year":"2017","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"3","key":"10.1016\/B978-0-443-33841-0.00030-0_bib29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.0b013e3181e8e8b8","article-title":"Comparing predictors of conversion and decline in mild cognitive impairment","volume":"75","author":"Landau","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/B978-0-443-33841-0.00030-0_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09577-4","article-title":"Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults","volume":"7","author":"Laws","year":"2017","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/B978-0-443-33841-0.00030-0_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.febslet.2007.12.035","article-title":"Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease","volume":"582","author":"Liu","year":"2008","journal-title":"FEBS Letters"},{"key":"10.1016\/B978-0-443-33841-0.00030-0_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00271","article-title":"Changes in cerebrospinal fluid Tau and \u03b2-amyloid levels in diabetic and prediabetic patients: A meta-analysis","volume":"10","author":"Lu","year":"2018","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"2","key":"10.1016\/B978-0-443-33841-0.00030-0_bib33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JAD-150493","article-title":"Metformin in amnestic mild cognitive impairment: Results of a pilot randomized placebo controlled clinical trial","volume":"51","author":"Luchsinger","year":"2016","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"2","key":"10.1016\/B978-0-443-33841-0.00030-0_bib34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3892\/mmr.2012.1186","article-title":"MTOR and tau phosphorylated proteins in the hippocampal tissue of rats with type 2 diabetes and Alzheimer\u2019s disease","volume":"7","author":"Ma","year":"2013","journal-title":"Molecular Medicine Reports"},{"issue":"4","key":"10.1016\/B978-0-443-33841-0.00030-0_bib35","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.nlm.2010.02.002","article-title":"Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance","volume":"93","author":"McNay","year":"2010","journal-title":"Neurobiology of Learning and Memory"},{"key":"10.1016\/B978-0-443-33841-0.00030-0_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101234","article-title":"The brain as an insulin-sensitive metabolic organ","volume":"52","author":"Milstein","year":"2021","journal-title":"Molecular Metabolism"},{"key":"10.1016\/B978-0-443-33841-0.00030-0_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.718942","article-title":"A critical review of the evidence that metformin is a putative anti-aging drug that enhances healthspan and extends lifespan","volume":"12","author":"Mohammed","year":"2021","journal-title":"Frontiers in Endocrinology"},{"issue":"1","key":"10.1016\/B978-0-443-33841-0.00030-0_bib38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbadis.2009.10.006","article-title":"Mitochondrial dysfunction is a trigger of Alzheimer\u2019s disease pathophysiology","volume":"1802","author":"Moreira","year":"2010","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"issue":"5","key":"10.1016\/B978-0-443-33841-0.00030-0_bib39","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","article-title":"FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer\u2019s disease","volume":"36","author":"Mosconi","year":"2009","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"4","key":"10.1016\/B978-0-443-33841-0.00030-0_bib40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40336-013-0026-y","article-title":"Glucose metabolism in normal aging and Alzheimer\u2019s disease: Methodological and physiological considerations for PET studies","volume":"1","author":"Mosconi","year":"2013","journal-title":"Clinical and Translational Imaging"},{"issue":"11","key":"10.1016\/B978-0-443-33841-0.00030-0_bib41","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1007\/s001250050588","article-title":"Association of diabetes mellitus and dementia: The Rotterdam Study","volume":"39","author":"Ott","year":"1996","journal-title":"Diabetologia"},{"issue":"47","key":"10.1016\/B978-0-443-33841-0.00030-0_bib42","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1523\/JNEUROSCI.1700-16.2016","article-title":"Novel roles for the insulin-regulated glucose transporter-4 in hippocampally dependent memory","volume":"36","author":"Pearson-Leary","year":"2016","journal-title":"Journal of Neuroscience"},{"issue":"11","key":"10.1016\/B978-0-443-33841-0.00030-0_bib43","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jamaneurol.2021.3126","article-title":"US food and drug administration approval of aducanumab - is amyloid load a valid surrogate end point for Alzheimer disease clinical trials?","volume":"78","author":"Planche","year":"2021","journal-title":"JAMA Neurology"},{"key":"10.1016\/B978-0-443-33841-0.00030-0_bib44","unstructured":"Prince, M., Wimo, A., Guerchet, M., Ali, G.-C., Wu, Y.-T., & Prina, M. (2015). The global impact of dementia: An analysis of prevalence, incidence, cost and trends. https:\/\/www.alzint.org\/u\/WorldAlzheimerReport2015.pdf."},{"issue":"9","key":"10.1016\/B978-0-443-33841-0.00030-0_bib45","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJMp2111320","article-title":"Controversy and progress in Alzheimer\u2019s disease - FDA approval of aducanumab","volume":"385","author":"Rabinovici","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/B978-0-443-33841-0.00030-0_bib46","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","article-title":"Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype","volume":"27","author":"Reger","year":"2006","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/B978-0-443-33841-0.00030-0_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00521","article-title":"Role of the blood-brain barrier in central nervous system insulin resistance","volume":"13","author":"Rhea","year":"2019","journal-title":"Frontiers in Neuroscience"},{"issue":"4","key":"10.1016\/B978-0-443-33841-0.00030-0_bib48","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.tpj.6500369","article-title":"Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer\u2019s disease","volume":"6","author":"Risner","year":"2006","journal-title":"Pharmacogenomics Journal"},{"issue":"1","key":"10.1016\/B978-0-443-33841-0.00030-0_bib49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3233\/JAD-190620","article-title":"Classification of clinically diagnosed Alzheimer\u2019s disease associated with diabetes based on amyloid and Tau PET results","volume":"71","author":"Takenoshita","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"11","key":"10.1016\/B978-0-443-33841-0.00030-0_bib50","first-page":"950","article-title":"Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: A preliminary study","volume":"13","author":"Watson","year":"2005","journal-title":"The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry"},{"issue":"5","key":"10.1016\/B978-0-443-33841-0.00030-0_bib51","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jalz.2014.03.011","article-title":"Insulin resistance predicts brain amyloid deposition in late middle-aged adults","volume":"11","author":"Willette","year":"2015","journal-title":"Alzheimer\u2019s and Dementia"},{"issue":"3","key":"10.1016\/B978-0-443-33841-0.00030-0_bib52","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00702-019-01975-4","article-title":"Dementia spectrum disorders: Lessons learnt from decades with PET research","volume":"126","author":"Wilson","year":"2019","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/B978-0-443-33841-0.00030-0_bib53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diabres.2016.10.024","article-title":"An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer\u2019s disease","volume":"124","author":"Zhang","year":"2017","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1016\/B978-0-443-33841-0.00030-0_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154265","article-title":"Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis","volume":"109","author":"Zhou","year":"2020","journal-title":"Metabolism: Clinical and Experimental"},{"issue":"11","key":"10.1016\/B978-0-443-33841-0.00030-0_bib55","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/jnr.24064","article-title":"The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction","volume":"95","author":"Zilberter","year":"2017","journal-title":"Journal of Neuroscience Research"}],"container-title":["Nutritional Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780443338410000300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780443338410000300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:55:23Z","timestamp":1769907323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780443338410000300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443338410"],"references-count":55,"URL":"https:\/\/doi.org\/10.1016\/b978-0-443-33841-0.00030-0","relation":{},"subject":[],"published":{"date-parts":[[2026]]}}}